Alessandro Bartolomucci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alessandro Bartolomucci has a total of 250 co-authors. Here are the top co-authors by number of shared publications:
Maria Razzoli
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, USA
24 shared publications- Maria Razzoli
Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, USA
12 shared publications Pedro Rodriguez
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, USA
9 shared publicationsCheryl Cero
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, 55455, USA
8 shared publicationsJean Pierre Pallais
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, USA
8 shared publicationsSeth McGonigle
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, USA
7 shared publications
Latest Publications
- 12 November 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (11) , 2291-2305
Animal models illuminate causal mechanisms of social determinants of aging to advance experimental social geroscience
- 12 November 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (11) , 2291-2305
Animal models illuminate causal mechanisms of social determinants of aging to advance experimental social geroscience
- Open Access
- 28 July 2026
- Published by Springer Nature in Cardio-Oncology
- Vol. 12 (1)
Psychosocial stress exacerbates doxorubicin-induced cardiotoxicity in adult C57BL/6N mice
- 28 July 2026
- Published by Springer Nature in Cardio-Oncology
- Vol. 12 (1)
Open AccessPsychosocial stress exacerbates doxorubicin-induced cardiotoxicity in adult C57BL/6N mice
- Open Access
Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity
Microglia, the resident macrophages of the central nervous system, are recognized for their heterogeneity and integral role in brain function and diseases. In the context of high fat diet (HFD) feeding and obesity, microglia become overactive, acquiring a prevailing lipid associated microglial phenotype (also known as LAM). Yet, how microgliosis is induced and regulated remains unclear. Here we report a key role for the Complement 3a Receptor (C3aR), on HFD-induced hypothalamic gliosis and weight gain in mice. HFD consumption leads to elevated microglial expression of C3aR, which parallels widespread accumulation of reactive microglia, selectively in the hypothalamus. Conditional microglial C3aR deletion protects mice from HFD-induced hypothalamic reactive microgliosis. C3aR deletion or pharmacological antagonism opposes HFD-induced weight gain in male but not female mice. Mechanistically, we demonstrated that C3aR is essential for lipid-induced lipid droplet formation, and acquisition of a LAM molecular signature. In summary, we uncovered a previously unknown role for C3aR in the acquisition of a LAM signature driving diet-induced gliosis, identifying this receptor as a new viable therapeutic candidate for conditions associated with hypothalamic neuroinflammation.
Open AccessComplement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity
Microglia, the resident macrophages of the central nervous system, are recognized for their heterogeneity and integral role in brain function and diseases. In the context of high fat diet (HFD) feeding and obesity, microglia become overactive, acquiring a prevailing lipid associated microglial phenotype (also known as LAM). Yet, how microgliosis is induced and regulated remains unclear. Here we report a key role for the Complement 3a Receptor (C3aR), on HFD-induced hypothalamic gliosis and weight gain in mice. HFD consumption leads to elevated microglial expression of C3aR, which parallels widespread accumulation of reactive microglia, selectively in the hypothalamus. Conditional microglial C3aR deletion protects mice from HFD-induced hypothalamic reactive microgliosis. C3aR deletion or pharmacological antagonism opposes HFD-induced weight gain in male but not female mice. Mechanistically, we demonstrated that C3aR is essential for lipid-induced lipid droplet formation, and acquisition of a LAM molecular signature. In summary, we uncovered a previously unknown role for C3aR in the acquisition of a LAM signature driving diet-induced gliosis, identifying this receptor as a new viable therapeutic candidate for conditions associated with hypothalamic neuroinflammation.
- Open Access
- 24 March 2026
- Published by Springer Nature in GeroScience
Revisiting the social frailty index in aging adults: relevance and implications for an emerging construct
Frailty is an established benchmark of aging-related decline, yet most measures of frailty focus on physical decline. Increasing evidence that social environments influence trajectories of aging has led to growing interest in social frailty. Recently, a 10-item Social Frailty Index (SFI-10) was developed using data from the Health and Retirement Study (HRS) that used 8 social items plus chronological age and sex to predict mortality. This study evaluates the validity of the SFI-10, providing considerations for social frailty measurement. Utilizing HRS cohorts ( n = 8264, ages 66 to 101) and cohorts from the Midlife in the United States (MIDUS) study ( n = 5619, ages 40 to 75), the SFI-10 was evaluated alongside an index including only its social-environmental factors (SFI-8). Logistic regressions were used to predict mortality from the SFI-10, SFI-8, and only age and sex. Within MIDUS, the SFI-10, SFI-8, and age were further evaluated against external criteria relevant for social frailty. Findings indicate that chronological age is the most important predictor of mortality risk across both samples. Social-environmental factors predict mortality only marginally in older adults but more strongly in midlife. When associated with external criteria relevant for social frailty, the SFI-8 exhibited stronger criterion validity than the SFI-10. These findings suggest that social frailty may be best reflected by measures focusing exclusively on social behaviors and resources, excluding demographic characteristics. Our work underscores the need for well-designed measures of social frailty.
- 24 March 2026
- Published by Springer Nature in GeroScience
Open AccessRevisiting the social frailty index in aging adults: relevance and implications for an emerging construct
Frailty is an established benchmark of aging-related decline, yet most measures of frailty focus on physical decline. Increasing evidence that social environments influence trajectories of aging has led to growing interest in social frailty. Recently, a 10-item Social Frailty Index (SFI-10) was developed using data from the Health and Retirement Study (HRS) that used 8 social items plus chronological age and sex to predict mortality. This study evaluates the validity of the SFI-10, providing considerations for social frailty measurement. Utilizing HRS cohorts ( n = 8264, ages 66 to 101) and cohorts from the Midlife in the United States (MIDUS) study ( n = 5619, ages 40 to 75), the SFI-10 was evaluated alongside an index including only its social-environmental factors (SFI-8). Logistic regressions were used to predict mortality from the SFI-10, SFI-8, and only age and sex. Within MIDUS, the SFI-10, SFI-8, and age were further evaluated against external criteria relevant for social frailty. Findings indicate that chronological age is the most important predictor of mortality risk across both samples. Social-environmental factors predict mortality only marginally in older adults but more strongly in midlife. When associated with external criteria relevant for social frailty, the SFI-8 exhibited stronger criterion validity than the SFI-10. These findings suggest that social frailty may be best reflected by measures focusing exclusively on social behaviors and resources, excluding demographic characteristics. Our work underscores the need for well-designed measures of social frailty.
- 15 February 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (4)
Social and clinical frailty indices in aging mice: a comparative analysis of longitudinal and cross-sectional designs
Aging is a heterogeneous phenomenon provoked by biological processes that still need to be fully understood. Frailty is a relevant outcome of aging reflecting biological decline that can be quantified through indices measuring the accumulation of functional deficits. Age-related declines may occur across multiple domains of functioning, and longitudinal study designs may better characterize decline within aging individuals. Thus, it is imperative to characterize how frailty indices that capture different functional domains associate with one another over the natural lifespan and across study designs. Here, the clinical frailty index (CFI) and the mouse social frailty index (mSFI) were applied to male and female mice both longitudinally and cross-sectionally over the lifespan. An overall similar association with aging was apparent: within each cohort, both CFI and mSFI were strongly positively associated with age. The utility of the CFI and mSFI as age predictors within the longitudinal study was confirmed. Critically, a model developed within the longitudinal study based on CFI scores, mSFI scores, and sex was able to predict age better than alternative models using only one of the indices. This result suggests that the CFI and the mSFI capture intrinsically different elements of deficit accumulation with age. The same model also showed a good performance in predicting the age of mice in the cross-sectional study. Overall, these results demonstrate that the information captured by both frailty indices is relevant to aging, relationships between indices vary across study design, and both frailty domains are needed to produce better age predictions.
- 15 February 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (4)
Social and clinical frailty indices in aging mice: a comparative analysis of longitudinal and cross-sectional designs
Aging is a heterogeneous phenomenon provoked by biological processes that still need to be fully understood. Frailty is a relevant outcome of aging reflecting biological decline that can be quantified through indices measuring the accumulation of functional deficits. Age-related declines may occur across multiple domains of functioning, and longitudinal study designs may better characterize decline within aging individuals. Thus, it is imperative to characterize how frailty indices that capture different functional domains associate with one another over the natural lifespan and across study designs. Here, the clinical frailty index (CFI) and the mouse social frailty index (mSFI) were applied to male and female mice both longitudinally and cross-sectionally over the lifespan. An overall similar association with aging was apparent: within each cohort, both CFI and mSFI were strongly positively associated with age. The utility of the CFI and mSFI as age predictors within the longitudinal study was confirmed. Critically, a model developed within the longitudinal study based on CFI scores, mSFI scores, and sex was able to predict age better than alternative models using only one of the indices. This result suggests that the CFI and the mSFI capture intrinsically different elements of deficit accumulation with age. The same model also showed a good performance in predicting the age of mice in the cross-sectional study. Overall, these results demonstrate that the information captured by both frailty indices is relevant to aging, relationships between indices vary across study design, and both frailty domains are needed to produce better age predictions.
- Open Access
- 23 December 2025
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (1) , 4
Substrain-Dependent Differences in Doxorubicin-Induced Cardiotoxicity in Adult C57BL/6 Mice
Doxorubicin (DOX)-induced cardiotoxicity is widely studied using C57BL/6 mice. However, potential substrain differences between C57BL/6J (6J) and C57BL/6N (6N) remain unexamined. Comparative studies are needed to improve preclinical reproducibility and translation. Fifteen-week-old male 6N and 6J mice received either DOX (8 mg/kg/week for 3 weeks) or saline. Body weight was monitored weekly, followed by echocardiography to assess cardiac function. Histopathology evaluated cardiac fibrosis, and bulk RNA sequencing identified differentially expressed genes, which were then validated by qPCR. DOX caused significant weight loss in 6N constituted by loss of both fat and fat-free mass, while 6J showed subtle changes. Echocardiography showed a significant ejection fraction decline only in 6J, while cardiac output, stroke volume, and heart weight were reduced in both. Gene expression analysis revealed significant upregulation of atrial natriuretic peptide and myosin heavy chains in both substrains, with B-type natriuretic peptide upregulation in 6N only. Transcriptomic analysis identified 518 upregulated and 203 downregulated genes in 6N, and 406 upregulated and 445 downregulated genes in 6J, with 113 and 115 commonly upregulated and downregulated genes, respectively. Gene set enrichment analysis revealed that DOX-treated 6N mice showed enrichment of TGF-beta signaling pathways, and suppression of IL-6–JAK–STAT3, epithelial-mesenchymal transition, and myogenesis pathways. In contrast, 6J exhibited enrichment of oxidative phosphorylation, p53 pathway, and reactive oxygen species pathways. Both substrains showed enrichment of apoptosis, unfolded protein response, TNFα signaling via NF-κB, and heme metabolism pathways and downregulation of Hedgehog Signaling and Interferon Gamma Response pathways. This study demonstrates substrain-dependent differences in DOX-induced cardiotoxicity, highlighting how genetic background affects cardiac function, gene expression, and pathway enrichment. Graphical Abstract Substrain-specific differences in doxorubicin-induced cardiotoxicity
- 23 December 2025
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (1) , 4
Open AccessSubstrain-Dependent Differences in Doxorubicin-Induced Cardiotoxicity in Adult C57BL/6 Mice
Doxorubicin (DOX)-induced cardiotoxicity is widely studied using C57BL/6 mice. However, potential substrain differences between C57BL/6J (6J) and C57BL/6N (6N) remain unexamined. Comparative studies are needed to improve preclinical reproducibility and translation. Fifteen-week-old male 6N and 6J mice received either DOX (8 mg/kg/week for 3 weeks) or saline. Body weight was monitored weekly, followed by echocardiography to assess cardiac function. Histopathology evaluated cardiac fibrosis, and bulk RNA sequencing identified differentially expressed genes, which were then validated by qPCR. DOX caused significant weight loss in 6N constituted by loss of both fat and fat-free mass, while 6J showed subtle changes. Echocardiography showed a significant ejection fraction decline only in 6J, while cardiac output, stroke volume, and heart weight were reduced in both. Gene expression analysis revealed significant upregulation of atrial natriuretic peptide and myosin heavy chains in both substrains, with B-type natriuretic peptide upregulation in 6N only. Transcriptomic analysis identified 518 upregulated and 203 downregulated genes in 6N, and 406 upregulated and 445 downregulated genes in 6J, with 113 and 115 commonly upregulated and downregulated genes, respectively. Gene set enrichment analysis revealed that DOX-treated 6N mice showed enrichment of TGF-beta signaling pathways, and suppression of IL-6–JAK–STAT3, epithelial-mesenchymal transition, and myogenesis pathways. In contrast, 6J exhibited enrichment of oxidative phosphorylation, p53 pathway, and reactive oxygen species pathways. Both substrains showed enrichment of apoptosis, unfolded protein response, TNFα signaling via NF-κB, and heme metabolism pathways and downregulation of Hedgehog Signaling and Interferon Gamma Response pathways. This study demonstrates substrain-dependent differences in DOX-induced cardiotoxicity, highlighting how genetic background affects cardiac function, gene expression, and pathway enrichment. Graphical Abstract Substrain-specific differences in doxorubicin-induced cardiotoxicity
- 16 October 2025
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 179, 106429
Fostering innovations in brain and behavioral sciences across health and disease over the lifecourse
- 16 October 2025
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 179, 106429
Fostering innovations in brain and behavioral sciences across health and disease over the lifecourse
- Open Access
- 3 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 19107-19121
A Novel Class of Complement 3a Receptor Agonists and Antagonists Derived from the TLQP-21 Peptide
The complement 3a receptor (C3aR) is a G-protein-coupled receptor (GPCR) involved in inflammatory, metabolic, and neurological diseases. Two endogenous ligands (C3a and TLQP-21) and small molecules (SB290157 and JR14a) differentially signal at C3aR, but these properties are not fully understood and need to be optimized with medicinal chemistry. Here, we generated rationally designed peptidergic analogues of TLQP-21 in an effort to extend the range of compounds with therapeutic potential beyond C3a-derived peptidergic agonists or small-molecule antagonists. We identified key arginines in the central portion of the peptide and the C-terminus, where mutation confers enhanced plasma stability. Mutations at the C-terminal motif alanine-arginine (-AlaArg), with unnatural amino acids and stereoisomers conferred signaling selectivity, enhanced peptide potency (e.g., DArg10_DAla20), or resulted in a functional antagonist (DArg10_Aib20). Overall, we increased our understanding of the C3aR mechanism of action, expanding and differentiating the range of therapeutic potentials for this GPCR.
- 3 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 19107-19121
Open AccessA Novel Class of Complement 3a Receptor Agonists and Antagonists Derived from the TLQP-21 Peptide
The complement 3a receptor (C3aR) is a G-protein-coupled receptor (GPCR) involved in inflammatory, metabolic, and neurological diseases. Two endogenous ligands (C3a and TLQP-21) and small molecules (SB290157 and JR14a) differentially signal at C3aR, but these properties are not fully understood and need to be optimized with medicinal chemistry. Here, we generated rationally designed peptidergic analogues of TLQP-21 in an effort to extend the range of compounds with therapeutic potential beyond C3a-derived peptidergic agonists or small-molecule antagonists. We identified key arginines in the central portion of the peptide and the C-terminus, where mutation confers enhanced plasma stability. Mutations at the C-terminal motif alanine-arginine (-AlaArg), with unnatural amino acids and stereoisomers conferred signaling selectivity, enhanced peptide potency (e.g., DArg10_DAla20), or resulted in a functional antagonist (DArg10_Aib20). Overall, we increased our understanding of the C3aR mechanism of action, expanding and differentiating the range of therapeutic potentials for this GPCR.
- Open Access
Ketone body driven lipid remodeling supports thermogenic adaptation to fasting
Metabolic adaptation to fasting may have conferred survival advantage to early humans and predicts weight gain caused by overnutrition in modern societies. Fasting suppresses brown adipose tissue (BAT) thermogenesis; however, it is unclear how BAT rewires cellular metabolism to balance between energy conservation and heat generation. Here, we report that BAT in mice under fasting and cold challenge consumed ketone bodies, specifically acetoacetate (AcAc). Ablating liver ketogenesis decreased, while enhancing hepatic AcAc output defended, body temperature in mice facing the dual challenge. Using stable isotope tracing in brown adipocytes in vitro combined with quantitative analysis of metabolic fluxes and lipidomics in BAT from genetic mouse models, we disentangled the two metabolic fates of AcAc - terminal oxidation in the mitochondria and lipid biosynthesis in the cytosol. Notably, AcAc-sourced carbon preferentially supported polyunsaturated fatty acid synthesis in BAT, linking to the positive impact of intermittent fasting on lipid profiles in both mice and humans. Therefore, ketone body utilization by thermogenic adipocytes contributes to metabolic resilience of mammals and can be targeted to optimize benefits of dietary regimens.
Open AccessKetone body driven lipid remodeling supports thermogenic adaptation to fasting
Metabolic adaptation to fasting may have conferred survival advantage to early humans and predicts weight gain caused by overnutrition in modern societies. Fasting suppresses brown adipose tissue (BAT) thermogenesis; however, it is unclear how BAT rewires cellular metabolism to balance between energy conservation and heat generation. Here, we report that BAT in mice under fasting and cold challenge consumed ketone bodies, specifically acetoacetate (AcAc). Ablating liver ketogenesis decreased, while enhancing hepatic AcAc output defended, body temperature in mice facing the dual challenge. Using stable isotope tracing in brown adipocytes in vitro combined with quantitative analysis of metabolic fluxes and lipidomics in BAT from genetic mouse models, we disentangled the two metabolic fates of AcAc - terminal oxidation in the mitochondria and lipid biosynthesis in the cytosol. Notably, AcAc-sourced carbon preferentially supported polyunsaturated fatty acid synthesis in BAT, linking to the positive impact of intermittent fasting on lipid profiles in both mice and humans. Therefore, ketone body utilization by thermogenic adipocytes contributes to metabolic resilience of mammals and can be targeted to optimize benefits of dietary regimens.